Symptoms and behavioral features induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in an old java monkey [Macaca cynamolgus fascicularis (Raffles)]
- 1 May 1986
- journal article
- research article
- Published by Elsevier in Brain Research Bulletin
- Vol. 16 (5) , 561-571
- https://doi.org/10.1016/0361-9230(86)90131-0
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- Permanent human parkinsonism due to 1‐methy 1–4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP)Neurology, 1985
- III. Primate model of parkinsonism: Selective lesion of nigrostriatal neurons by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine produces an extrapyramidal syndrome in rhesus monkeysLife Sciences, 1985
- Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in MiceScience, 1984
- Repeated administration of N-methyl-4-phenyl 1,2,5,6-tetrahydropyridine to rats is not toxic to striatal dopamine neuronesBiochemical Pharmacology, 1984
- Neurochemical and behavioral effects of systematic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the ratEuropean Journal of Pharmacology, 1984
- Neurotoxicity of the meperidine analogue N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on brain catecholamine neurons in the mouseEuropean Journal of Pharmacology, 1984
- Diagnostic problems in Parkinson's diseaseClinical Neurology and Neurosurgery, 1984
- Problems of levodopa treatmentClinical Neurology and Neurosurgery, 1984
- Chronic parkinsonism secondary to intravenous injection of meperidine analoguesPsychiatry Research, 1979
- A sterotaxic atlas for cebus monkeysJournal of Comparative Neurology, 1960